Please login to the form below

Not currently logged in
Email:
Password:

drug reimbursement

This page shows the latest drug reimbursement news and features for those working in and with pharma, biotech and healthcare.

The NHS at 70th: celebrations, renewed reforms and difficult choices

The NHS at 70th: celebrations, renewed reforms and difficult choices

that NHS England has not accepted their latest pricing and reimbursement offer on its cystic fibrosis drug Orkambi.

Latest news

  • Daily Brief: Azar blasts pharma, NICE forces MS drug prices down, Xenicos gets $30m funding

    sector. US drug prices. After Trump bluster, Azar gets serious on drug prices. ... of drug development, approval and reimbursement, and 2) truly wants to see thoughtful reforms.”.

  • Connecting the dots Connecting the dots

    Not just any drug mind you - a decades-old corticosterioid called Emflaza (deflazacort) that is available elsewhere for about $1, 500 per year. ... And, by the way, faster drug approvals are meaningless without reimbursement coverage (something I have

  • French pharma growth restricted by generics French pharma growth restricted by generics

    Such government spending funds France's extensive healthcare reimbursement system, which sees the state health system pay money back into citizens' accounts after they have paid for a service, such as ... If a drug is approved for reimbursement it will

  • No further price cut for non-PPRS drugs in UK No further price cut for non-PPRS drugs in UK

    The DH announced in November 2013 that it would reduce the cost of these statutory medicines by 15% as part of wider drug pricing negotiations and there were concerns that this ... Also weighing in was the Ethical Medicines Industry Group, representing

  • No further price cut for non-PPRS drugs in UK No further price cut for non-PPRS drugs in UK

    The DH announced in November 2013 that it would reduce the cost of these statutory medicines by 15% as part of wider drug pricing negotiations and there were concerns that this ... Also weighing in was the Ethical Medicines Industry Group, representing

More from news
Approximately 38 fully matching, plus 66 partially matching documents found.

Latest Intelligence

  • When science is not enough When science is not enough

    a drug’s chances of reimbursement. ... BEACON makes it easier for different stakeholders to communicate during a drug’s development.

  • Market access improvements in Turkey Market access improvements in Turkey

    In 2015 there were 8, 104 products on the reimbursement list, with 292 new ones added. ... Reimbursement pricing. A decree on drug pricing (2015/7752) appeared in July 2015 and was implemented by a communiqué last December.

  • Making savings from European drugs budgets Making savings from European drugs budgets

    Assessing value in Sweden, Germany and the UK. Sofia Wollstrom, director-general of the Dental and Pharmaceutical Benefits Agency (which decides on drug pricing and reimbursement in Sweden), told PME that ... GBA [which has the final say on drug

  • Turkey's pharma market is ripe for profitability Turkey's pharma market is ripe for profitability

    Koçsel. This new production facility could take Turkey into the realms of leading the global oncological drug field through the 184 different products that it seeks to develop in its portfolio.

  • Allergan and taking a specialised approach Allergan and taking a specialised approach

    This approach makes it easier when it comes to the reimbursement stage of drug development, which has proven to be a cause of concern for many companies who struggle to gain ... Both Navarre and Boland agree it's a drug the company is very proud of, but

More from intelligence
Approximately 7 fully matching, plus 14 partially matching documents found.

Latest appointments

  • Extension for head of Germany’s VFA Extension for head of Germany’s VFA

    She has led the industry voice during an unsettled time for pharma in Germany with many companies critical of the AMNOG system of drug reimbursement introduced in 2010, which has seen

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics